Standard Operating Procedure for Compilation of Electronic Submission Packages
| Department | Regulatory Affairs |
| SOP No. | RA/2026/692 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 12/04/2026 |
| Effective Date | 12/04/2026 |
| Review Date | 12/04/2028 |
Purpose
This Standard Operating Procedure (SOP) establishes a consistent and controlled process for the compilation of electronic submission packages in the regulatory affairs department. It ensures that all electronic submissions are complete, accurate, and compliant with applicable regulatory requirements and company quality standards. The SOP supports the control objective of maintaining data integrity, traceability, and regulatory compliance during preparation, review, and dispatch of electronic dossiers for regulatory submissions.
Scope
This SOP applies to all activities related to the compilation of electronic submission packages within the Regulatory Affairs department. It covers compilation processes for submissions involving various product types including pharmaceuticals, biologics, and medical devices, across all dosage forms and functional areas. The procedure addresses preparation, assembly, quality control, and dispatch readiness of electronic dossiers for regulatory authorities. This SOP does not cover actual document authorship, regulatory strategy decisions, or submission tracking post-dispatch.
Responsibilities
– Regulatory Affairs Specialists: Prepare and compile electronic documents as per dossier structure requirements.
– Quality Control Reviewers: Perform quality checks and technical reviews on compiled packages.
– Regulatory Affairs Supervisors: Oversee compilation activities and ensure adherence to timelines and compliance.
– Document Control: Manage version control and secure storage of submission packages.
– Approval Authorities: Review and approve final electronic submission packages prior to dispatch.
Accountability
The Head of Regulatory Affairs is accountable for the implementation, compliance monitoring, periodic review, and continuous improvement of this SOP. They are also responsible for escalating major issues impacting compilation quality or regulatory compliance and ensuring appropriate training of personnel involved in the compilation process.
Procedure
1. Preparation and Prerequisites:
Ensure that all individual submission documents have been finalized, approved, and are available in their latest controlled versions. Confirm that the dossier structure and submission requirements (e.g., eCTD or NeeS format) are clearly defined as per regulatory guidelines.
2. System and Equipment Readiness:
Verify that the electronic document management systems and compilation software tools are functioning correctly and access permissions are current. Check the availability of required templates, controlled vocabularies, and metadata standards.
3. Compilation Process:
Initiate compilation by organizing documents based on the approved dossier structure. Integrate the finalized PDF files or electronic documents into the submission sequence. Ensure bookmarks, hyperlinks, and cross-references within the package are accurate and functional.
4. In-process Controls and Quality Checks:
Conduct a preliminary review to verify completeness of all modules and sections. Check document formats, file sizes, and naming conventions comply with regulatory specifications.
Perform automated and manual quality control to detect any inconsistencies, missing pages, metadata errors, or corrupted files.
5. Verification and Acceptance Criteria:
Confirm that the compiled submission package passes all validation criteria, including folder structure, index files, checksum verification, and compliance with regulatory authority specifications.
Ensure final approval is obtained from the responsible regulatory officer before dispatch.
6. Handling Deviations:
If discrepancies or deficiencies are identified during compilation or QC, record the deviations in the quality management system. Initiate corrective actions as necessary, document investigations, and recompile the package upon resolution.
7. Documentation and Record Retention:
Maintain comprehensive records of compilation activities, QC checklists, approval logs, and submission readiness certificates. Version control all submitted packages and archive in electronic and physical repositories following company document retention policies.
8. Dispatch Preparation and Closure:
Prepare dispatch documentation including submission cover letters, transmittal forms, and delivery tracking logs. Confirm authorized signatures where applicable.
Submit the electronic package to the regulatory authority via approved channels and file evidence of submission receipt.
Update submission tracking logs post-dispatch and formally close the compilation activity.
This procedure ensures a robust, traceable, and compliant compilation process suited for any regulated product submission, adaptable across multiple functional units within the pharmaceutical and biotechnology industries.
Abbreviations
eCTD – Electronic Common Technical Document
NeeS – Non-eCTD electronic Submission
QC – Quality Control
RA – Regulatory Affairs
SOP – Standard Operating Procedure
PDF – Portable Document Format
GMP – Good Manufacturing Practice
Documents
The following documents are essential for the compilation of electronic submission packages:
- Compilation Checklist for Electronic Submission Packages (Annexure-1)
- Electronic Submission Package Quality Control Report (Annexure-2)
- Submission Dispatch Confirmation Form (Annexure-3)
References
– ICH M4 eCTD Guidelines
– FDA Electronic Submission Gateway (ESG) Requirements
– EU Guidance on Electronic Submissions
– Company Document Control Policy
– Regulatory Authority Specific Submission Specifications
– Good Documentation Practices (GDP) standards
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Compilation Checklist for Electronic Submission Packages
| Item | Description | Status | Comments |
|---|---|---|---|
| 1 | All documents finalized and approved | Yes | Completed on 10/04/2026 |
| 2 | Dossier structure verified and aligned with submission type | Yes | Consistent with ICH M4 eCTD |
| 3 | File names and formats checked | Yes | All files PDF/A compliant |
| 4 | Bookmarks and hyperlinks validated | Yes | Functionality verified |
| 5 | Metadata entries completed | Yes | Checked by RA Specialist |
| 6 | Version control confirmed | Yes | All documents matched with records |
| 7 | Preliminary review approved | Yes | Reviewed on 11/04/2026 |
Annexure-2: Electronic Submission Package Quality Control Report
| Check Item | Result | Observed By | Date | Remarks |
|---|---|---|---|---|
| Completeness of all modules | Pass | Quality Reviewer | 11/04/2026 | No missing files |
| File format compliance | Pass | Quality Reviewer | 11/04/2026 | All files PDF/A or as specified |
| Hyperlink and bookmarking test | Pass | Quality Reviewer | 11/04/2026 | All links functional |
| Checksum validation | Pass | Quality Reviewer | 11/04/2026 | Consistent with original files |
| Regulatory compliance check | Pass | Quality Reviewer | 11/04/2026 | Meets FDA and EMA guidelines |
| Final approval status | Approved | Regulatory Supervisor | 12/04/2026 | Ready for submission |
Annexure-3: Submission Dispatch Confirmation Form
| Submission ID | SUB20260412-001 |
| Submission Date | 12/04/2026 |
| Submission Method | Electronic via FDA ESG |
| Package Version | 1.0 |
| Dispatch Responsible Person | Regulatory Affairs Specialist |
| Submission Receipt Confirmation | Received on 12/04/2026 at 16:30 |
| Remarks | Successful upload, no errors reported |
| Signature of Dispatcher | _____________________ |
| Date | 12/04/2026 |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 12/04/2026 | 1.0 | Initial issue | New SOP creation |